Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

525
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
525
Glaucoma: Overview01:25

Glaucoma: Overview

695
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
695
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.9K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

650
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
650
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

331
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
331

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two-Year Performance and Safety Results of the MINIject Supraciliary Implant in Patients With Primary Open-Angle Glaucoma: Meta-Analysis of the STAR-I, II, III Trials.

American journal of ophthalmology·2023
Same author

Two-year outcomes of the MINIject drainage system for uncontrolled glaucoma from the STAR-I first-in-human trial.

The British journal of ophthalmology·2020
Same author

A European Study of the Performance and Safety of MINIject in Patients With Medically Uncontrolled Open-angle Glaucoma (STAR-II).

Journal of glaucoma·2020
Same author

A First-in-Human Study of the Efficacy and Safety of MINIject in Patients with Medically Uncontrolled Open-Angle Glaucoma (STAR-I).

Ophthalmology. Glaucoma·2020
Same author

Patient-reported prevalence of metamorphopsia and predictors of vision-related quality of life in vitreomacular traction: a prospective, multi-centre study.

Eye (London, England)·2018
Same author

[Required Framework for the Collection of Real-life Data: An Example from University Eye Hospital Munich].

Klinische Monatsblatter fur Augenheilkunde·2017

Related Experiment Video

Updated: Aug 22, 2025

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature
05:54

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature

Published on: January 24, 2025

390

Does Diabetes Influence Adherence in Glaucoma Patients?

Qifan Felix Zhao1, Christoph Hirneiss1

  • 1Glaukomsprechstunde, Augenklinik und Poliklinik des Klinikums der Universität München, München, Deutschland.

Klinische Monatsblatter Fur Augenheilkunde
|November 9, 2022
PubMed
Summary
This summary is machine-generated.

Patient adherence to glaucoma eye drops and follow-up appointments is critical but challenging. This study investigates if diabetes impacts adherence in glaucoma patients, a crucial area for chronic disease management.

More Related Videos

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
07:41

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Published on: October 23, 2020

6.0K
Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish
05:49

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish

Published on: May 5, 2021

4.9K

Related Experiment Videos

Last Updated: Aug 22, 2025

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature
05:54

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature

Published on: January 24, 2025

390
Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
07:41

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Published on: October 23, 2020

6.0K
Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish
05:49

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish

Published on: May 5, 2021

4.9K

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Pharmacology

Background:

  • Patient adherence is vital for managing chronic diseases like glaucoma, influencing treatment success and disease progression.
  • Adherence challenges in glaucoma include medication (eye drops) and follow-up appointments, with significant variability in reported adherence rates.
  • Diabetes mellitus is a risk factor for certain glaucomas and is associated with generally lower patient adherence, prompting investigation into its specific impact on glaucoma patient adherence.

Purpose of the Study:

  • To determine if a diabetes diagnosis is associated with reduced adherence to medication and follow-up in glaucoma patients.
  • To explore the relationship between diabetes and adherence in glaucoma, considering previous conflicting findings.

Main Methods:

  • Review of existing literature on glaucoma patient adherence.
  • Analysis of factors influencing adherence, including medication administration errors and follow-up appointment attendance.
  • Examination of studies investigating the link between diabetes, HbA1c levels, and adherence in glaucoma.

Main Results:

  • Glaucoma patient adherence to eye drops averages around 70%, with only about 50% achieving good adherence (≥80%).
  • A notable percentage of eye drops (6.8–31.4%) miss the eye, reducing therapeutic efficacy.
  • Previous studies show mixed results on diabetes association with reduced glaucoma adherence, though elevated HbA1c has been linked to adherence in some cases.

Conclusions:

  • Adherence remains a significant challenge for glaucoma patients, impacting treatment effectiveness.
  • The association between diabetes and reduced adherence in glaucoma requires further investigation with larger sample sizes.
  • Understanding adherence barriers in diabetic glaucoma patients is crucial for optimizing chronic disease management.